By Lexaria Bioscience Corp. on Tuesday, 07 May 2019
Category: Pharmaceutical - BioTech

Lexaria Bioscience inks US partnership to produce CBD beverages

viewLexaria Bioscience Corp.

The company is pairing its DehydraTECH system with a Nevada-based private company

The Kelowna, British Columbia company also announced it would issue 790,000 stock options

() (OTCMKTS:LXRP) is dishing out its signature infusion technology to build a better cannabidiol beverage.

Through its subsidiary Lexaria Hemp Corp, the company is pairing its DehydraTECH system with a Nevada-based private company to create CBD beverages for sale in the US.

DehydraTECH is the company’s method of delivering anything from vitamins to nicotine to CBD in order to maximize absorption, speed and taste.

READ: Lexaria Bioscience welcomes four new experts to advisory board to guide ongoing research

The deal is expected to last five years, although no financial details nor the company’s name, was disclosed.

The Kelowna, British Columbia company also announced it would issue 790,000 stock options to directors, an offer and its employees at an exercise price of C$0.99 per share.

Lexaria is focused on developing healthier ingestion methods and fast-acting, pleasant-tasting products. DehydraTECH is patented in the US and Australia, and the company has patents pending in 40 countries.

Contact Andrew Kessel at [email protected]

Follow him on @andrew_kessel

CSE:LXX

Market: CSE
Market Cap: $52.47 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Buds & Duds: Cannabis stocks hold steady; Lexaria rises on amended agreement...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched 0.2% higher at 122.9 points. Elsewhere, the OTCQX Cannabis index lost 0.2% to 489.3 points. Buds today are Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP), Curaleaf Holdings Inc...

1 week, 5 days ago

2 min read

Related Posts